Illini Twig
Thanks for your valuable input.
The members of your Rett community have a choice of Phase 3 trials and you have indicated that they are strongly favouring the trofinetide trial.
Are you able to provide any insight into reasons for the community's apparent lack of interest in the Epidiolex trial?
Head to head, page-34
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.00 |
Change
-0.020(0.15%) |
Mkt cap ! $1.660B | |||
| Open | High | Low | Value | Volume |
| $13.06 | $13.26 | $12.81 | $4.525M | 348.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 515 | $12.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.00 | 703 | 12 |
View Market Depth
| Last trade - 15.50pm 15/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |